A new distribution partnership expands Elemental Machines’ reach in Europe to bring innovative technologies to the European market CAMBRIDGE, Mass. – Elemental Machines, developer of the Intelligent Operations Platform have entered into a partnership with System-c bioprocess as an authorized reseller of Elemental Machines’ hardware solutions, servicing the biopharmaceutical industry in France. The partnership will allow Elemental Machines […]

SINGAPORE — Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, have announced an extended research partnership that will focus on deep immunophenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated […]

Leiden – MIMETAS, a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company. The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in our longstanding collaboration with […]

MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced new workflows developed with global agriculture company, Corteva Agriscience that enable high throughput plant and microbial genome sequencing. This collaboration, which originated at the Advances in Genome Biology and Technology (AGBT) Agricultural meeting last year, delivers end-to-end workflows that streamline DNA extraction […]

SAN CARLOS, Calif. — Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, has announced a collaboration with Watchmaker Genomics, a life sciences company that specializes in developing high-stringency applications for reading, writing, and editing of DNA and RNA. This collaboration will focus on further optimizing a disruptive technology that enables […]

Elemental Machines is excited to announce its collaboration with Evertreen to support the environment by planting a tree for every order placed. Evertreen is an organization that offers a global platform enabling users to plant real trees online and track them via satellite. Through this collaboration, Elemental Machines will contribute to Evertreen’s tree planting projects which are active […]

ACD/Labs will combine their expertise in chemical information management with the knowledge and expertise of ELSIE consortium members to create a searchable knowledge repository of pre‑competitive data. ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced a collaboration with the Extractables and Leachables Safety Information Exchange (ELSIE) consortium of […]

Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and safety assurance than ever before. Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integration Site […]

Oxford Nanopore’s devices with 4bases kits will enable decentralised, flexible scalability with a significant decrease in turnaround time for clinical researchers in Italy and Switzerland, with a first target of same-day BRCA1 and BRCA2 analysis. Oxford Nanopore Technologies plc (Oxford Nanopore) and 4bases, a Switzerland-based company, specialising in kits for sequencing and bioinformatic tools, today announce […]

Researchers can now access over 8,000 patient-derived xenografts (PDX), cell-derived xenografts (CDX), organoids and cell lines from Scientist.com’s AI-powered Disease Model Finder SAN DIEGO — Scientist.com, the premier R&D marketplace for the biopharmaceutical industry, announced today that it has partnered with leading contract research organizations (CROs), including Crown Bioscience, Imagen Therapeutics and Experimental Pharmacology & Oncology Berlin-Buch (EPO) to boost […]